JPH11508762A5 - - Google Patents
Info
- Publication number
- JPH11508762A5 JPH11508762A5 JP1996535139A JP53513996A JPH11508762A5 JP H11508762 A5 JPH11508762 A5 JP H11508762A5 JP 1996535139 A JP1996535139 A JP 1996535139A JP 53513996 A JP53513996 A JP 53513996A JP H11508762 A5 JPH11508762 A5 JP H11508762A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/446,918 US5705151A (en) | 1995-05-18 | 1995-05-18 | Gene therapy for T cell regulation |
| US446,918 | 1995-05-18 | ||
| US08/580,806 US5935568A (en) | 1995-05-18 | 1995-12-29 | Gene therapy for effector cell regulation |
| US580,806 | 1995-12-29 | ||
| PCT/US1996/007432 WO1996036366A1 (en) | 1995-05-18 | 1996-05-20 | Gene therapy for effector cell regulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH11508762A JPH11508762A (ja) | 1999-08-03 |
| JPH11508762A5 true JPH11508762A5 (enExample) | 2004-07-08 |
Family
ID=27034800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP8535139A Ceased JPH11508762A (ja) | 1995-05-18 | 1996-05-20 | エフェクタ細胞調節用遺伝子療法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5935568A (enExample) |
| EP (1) | EP0850071A4 (enExample) |
| JP (1) | JPH11508762A (enExample) |
| KR (1) | KR19990014875A (enExample) |
| AU (1) | AU704012B2 (enExample) |
| CA (1) | CA2221305A1 (enExample) |
| MX (1) | MX9708854A (enExample) |
| WO (1) | WO1996036366A1 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6075119A (en) | 1997-04-07 | 2000-06-13 | The Rockefeller University | Peptides useful for reducing symptoms of toxic shock syndrome |
| US6713284B2 (en) | 1997-06-25 | 2004-03-30 | The United States Of America As Represented By The Secretary Of The Army | Bacterial superantigen vaccines |
| US6977074B2 (en) | 1997-07-10 | 2005-12-20 | Mannkind Corporation | Method of inducing a CTL response |
| BR9815493A (pt) * | 1997-07-21 | 2000-10-31 | Pharmacia & Upjohn Ab | Citólise dirigida de células-alvo, agentes e composições que causam citólise, e compostos que podem ser usados para produzir os agentes |
| US7795020B2 (en) | 1998-01-14 | 2010-09-14 | Morphogenesis, Inc. | Tumor cell vaccines |
| WO1999036433A2 (en) * | 1998-01-14 | 1999-07-22 | Morphogenesis, Inc. | Materials and methods for treating oncological disease |
| US7348015B2 (en) | 1998-01-14 | 2008-03-25 | Morphogenesis, Inc. | Antigen modified cancer cell vaccines for cancer therapy |
| AU749625B2 (en) * | 1998-01-16 | 2002-06-27 | Johns Hopkins University, The | Oral delivery of nucleic acid vaccines by particulate complexes |
| CA2792479A1 (en) * | 1998-02-27 | 1999-09-02 | The Trustees Of The University Of Pennsylvania | Vaccines, immunotherapeutics and methods for using the same |
| DE69837350T2 (de) * | 1998-04-20 | 2007-11-29 | Torrey Pines Institute For Molecular Studies, San Diego | Topische immunostimulierung zur induzierung der migration der langerhanszellen |
| EP1073749B1 (en) * | 1998-04-22 | 2006-01-11 | Chiron Corporation | Enhancing immune responses to genetic immunization by using a chemokine |
| US6919318B1 (en) | 1998-04-22 | 2005-07-19 | Chiron Corporation | Enhancing immune responses to genetic immunization by using a chemokine |
| EP1089751A4 (en) * | 1998-06-23 | 2001-07-25 | Univ Leland Stanford Junior | Adjuvant therapy |
| US20040247662A1 (en) * | 1998-06-25 | 2004-12-09 | Dow Steven W. | Systemic immune activation method using nucleic acid-lipid complexes |
| US20030022854A1 (en) * | 1998-06-25 | 2003-01-30 | Dow Steven W. | Vaccines using nucleic acid-lipid complexes |
| DE69940157D1 (en) * | 1998-07-10 | 2009-02-05 | U S Medical Res Inst Of Infect | Anthrax-impfstoff |
| EP1105154B1 (en) * | 1998-08-13 | 2016-06-01 | Walter Reed Army Institute of Research | Bacterial superantigen vaccines |
| WO2000020598A1 (en) * | 1998-10-07 | 2000-04-13 | The Rockefeller University | Peptides useful for reducing symptoms of toxic shock syndrome and septic shock |
| US6562800B1 (en) * | 1998-10-30 | 2003-05-13 | University Of Southern California | Use of immunopotentiating sequences for inducing immune response |
| AU5178800A (en) * | 1999-06-01 | 2000-12-18 | Cornell Research Foundation Inc. | Activation of dendritic cells to enhance immunity |
| US7361329B2 (en) * | 2000-04-21 | 2008-04-22 | Chemocentryx, Inc. | Compositions for inducing an immune response |
| EP2110385A1 (en) | 2001-06-14 | 2009-10-21 | The Scripps Research Institute | Stabilized factor VIII with engineered disulfide bonds |
| SE0102327D0 (sv) | 2001-06-28 | 2001-06-28 | Active Biotech Ab | A novel engineered superantigen for human therapy |
| WO2003035106A1 (en) * | 2001-10-24 | 2003-05-01 | Chemocentryx | Methods and compositions for inducing an immune response by co-administering a chemokine with an antigen |
| WO2004044155A2 (en) * | 2002-11-07 | 2004-05-27 | Beth Israel Deaconess Medical Center | MIP-1α AND GM-CSF AS ADJUVANTS OF IMMUNE RESPONSE |
| WO2005023853A1 (ja) | 2003-09-05 | 2005-03-17 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | プロテアーゼ耐性ｓｅｂ改変体およびそれを含むワクチン |
| CA2863532A1 (en) * | 2012-02-08 | 2013-08-15 | Premune Ab | Prevention of inflammatory disorders in domestic non-human mammals |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5145676A (en) * | 1981-09-08 | 1992-09-08 | The Rockefeller University | Method and agents for promoting wound healing |
| US4994369A (en) * | 1987-12-15 | 1991-02-19 | The Board Of Trustees Of The Leland Stanford Jr. Univ. | T-cell activation related gene |
| US5703055A (en) * | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| WO1991004272A1 (en) * | 1989-09-19 | 1991-04-04 | N.V. Innogenetics S.A. | Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis |
| SE8903100D0 (sv) * | 1989-09-20 | 1989-09-20 | Pharmacia Ab | New pharmaceutical agent |
| DE69133484T2 (de) * | 1990-01-17 | 2006-05-18 | Terman, David S., Pepple Beach | Verwendung von Staphylococcus-Enterotoxinen oder verwandte Verbindungen für Krebs-Therapie |
| WO1993024136A1 (en) * | 1991-01-17 | 1993-12-09 | Terman David S | Tumor killing effects of enterotoxins, superantigens, and related compounds |
| EP0499003A1 (en) * | 1991-02-14 | 1992-08-19 | N.V. Innogenetics S.A. | Polypeptides and peptides, particularly recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnosis of tuberculosis |
| US5858784A (en) * | 1991-12-17 | 1999-01-12 | The Regents Of The University Of California | Expression of cloned genes in the lung by aerosol- and liposome-based delivery |
| WO1994004196A1 (en) * | 1992-08-14 | 1994-03-03 | Imperial Cancer Research Technology Limited | Tumour therapy |
| US5593972A (en) * | 1993-01-26 | 1997-01-14 | The Wistar Institute | Genetic immunization |
| WO1995000178A1 (en) * | 1993-06-25 | 1995-01-05 | Board Of Regents, The University Of Texas System | Pore-forming and superantigen encoding toxin cassettes for gene therapy |
-
1995
- 1995-12-29 US US08/580,806 patent/US5935568A/en not_active Expired - Fee Related
-
1996
- 1996-05-20 WO PCT/US1996/007432 patent/WO1996036366A1/en not_active Ceased
- 1996-05-20 CA CA002221305A patent/CA2221305A1/en not_active Abandoned
- 1996-05-20 AU AU58016/96A patent/AU704012B2/en not_active Ceased
- 1996-05-20 JP JP8535139A patent/JPH11508762A/ja not_active Ceased
- 1996-05-20 KR KR1019970708220A patent/KR19990014875A/ko not_active Withdrawn
- 1996-05-20 EP EP96914743A patent/EP0850071A4/en not_active Withdrawn
-
1997
- 1997-11-17 MX MX9708854A patent/MX9708854A/es not_active Application Discontinuation